Barclays’s scPharmaceuticals SCPH Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $252K | Buy |
66,199
+19,586
| +42% | +$74.6K | ﹤0.01% | 3397 |
|
|
2025
Q1 | $122K | Sell |
46,613
-18,748
| -29% | -$49.1K | ﹤0.01% | 3603 |
|
|
2024
Q4 | $232K | Buy |
65,361
+24,717
| +61% | +$87.7K | ﹤0.01% | 3445 |
|
|
2024
Q3 | $186K | Buy |
40,644
+30,902
| +317% | +$141K | ﹤0.01% | 3524 |
|
|
2024
Q2 | $43K | Sell |
9,742
-10,562
| -52% | -$46.6K | ﹤0.01% | 3727 |
|
|
2024
Q1 | $102K | Sell |
20,304
-19,381
| -49% | -$97.4K | ﹤0.01% | 3638 |
|
|
2023
Q4 | $249K | Buy |
39,685
+34,563
| +675% | +$217K | ﹤0.01% | 3416 |
|
|
2023
Q3 | $37K | Sell |
5,122
-634
| -11% | -$4.58K | ﹤0.01% | 3717 |
|
|
2023
Q2 | $58K | Sell |
5,756
-67,692
| -92% | -$682K | ﹤0.01% | 3611 |
|
|
2023
Q1 | $666K | Buy |
+73,448
| New | +$666K | ﹤0.01% | 2435 |
|
|
2021
Q4 | – | Sell |
-814
| Closed | -$5K | – | 3755 |
|
|
2021
Q3 | $5K | Buy |
814
+44
| +6% | +$270 | ﹤0.01% | 3829 |
|
|
2021
Q2 | $5K | Sell |
770
-5,079
| -87% | -$33K | ﹤0.01% | 3964 |
|
|
2021
Q1 | $39K | Buy |
5,849
+3,591
| +159% | +$23.9K | ﹤0.01% | 3562 |
|
|
2020
Q4 | $12K | Sell |
2,258
-865
| -28% | -$4.6K | ﹤0.01% | 3433 |
|
|
2020
Q3 | $24K | Buy |
3,123
+138
| +5% | +$1.06K | ﹤0.01% | 3469 |
|
|
2020
Q2 | $22K | Buy |
+2,985
| New | +$22K | ﹤0.01% | 3556 |
|
|
2019
Q4 | – | Sell |
-142
| Closed | -$1K | – | 4174 |
|
|
2019
Q3 | $1K | Buy |
142
+141
| +14,100% | +$993 | ﹤0.01% | 4057 |
|
|
2019
Q2 | $0 | Sell |
1
-2,086
| -100% | – | ﹤0.01% | 4397 |
|
|
2019
Q1 | $6K | Buy |
2,087
+1,890
| +959% | +$5.43K | ﹤0.01% | 4058 |
|
|
2018
Q4 | $1K | Sell |
197
-2,521
| -93% | -$12.8K | ﹤0.01% | 4026 |
|
|
2018
Q3 | $16K | Buy |
2,718
+2,000
| +279% | +$11.8K | ﹤0.01% | 3955 |
|
|
2018
Q2 | $3K | Sell |
718
-807
| -53% | -$3.37K | ﹤0.01% | 4062 |
|
|
2018
Q1 | $19K | Buy |
+1,525
| New | +$19K | ﹤0.01% | 3852 |
|